Compare BHM & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHM | NMTC |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7M | 29.2M |
| IPO Year | 2022 | 2010 |
| Metric | BHM | NMTC |
|---|---|---|
| Price | $8.88 | $1.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $15.00 | $11.90 |
| AVG Volume (30 Days) | 4.0K | ★ 765.0K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,734,000.00 | $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 36.88 | ★ 163.47 |
| 52 Week Low | $8.05 | $0.55 |
| 52 Week High | $13.59 | $5.40 |
| Indicator | BHM | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 44.50 |
| Support Level | $8.11 | $0.66 |
| Resistance Level | $9.55 | $1.98 |
| Average True Range (ATR) | 0.32 | 0.32 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 0.00 | 20.94 |
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.